This study evaluated various quantitative criteria for analysis of bre
ast imaging with PET using the radiolabeled glucose analog F-18-fluoro
deoxyglucose (FDG), Methods: In a prospective study, 73 patients with
abnormal mammography or palpable breast masses scheduled for biopsy we
re investigated with PET, A total of 97 breast tumors were evaluated b
y histology, including 46 benign and 51 malignant tumors. Using a whol
e-body PET scanner, attenuation-corrected images were acquired between
40 and 60 min after tracer injection, For Patlak analysis, dynamic da
ta acquisition was obtained in 24 patients, To differentiate between b
enign and malignant breast tumors, receiver operating characteristic c
urves were calculated using incrementally increasing threshold values
for tumor/nontumor ratios based on average and maximum activity values
per region of interest, standardized uptake values (corrected for par
tial volume effect, normalized to blood glucose, partial volume effect
and blood glucose, using the lean body mass as well as the body surfa
ce area) and calculating the FDG influx rate (K) assessed by Patlak an
alysis, Results: Quantification of FDG uptake in breast tumors provide
d objective criteria for differentiation between benign and malignant
tissue with similar diagnostic accuracy as compared with visual analys
is, Applying correction for partial volume effect and normalization by
blood glucose yielded the highest diagnostic accuracy. Conclusions: T
hese quantitative methods provided accurate evaluation of PET data for
differentiating benign from malignant breast tumors. Quantitative ass
essment is recommended to complement visual image interpretation with
the potential benefit of reduced interobserver variability.